TSL.L Regulatory News (TSL)

19 Dec 2006 14:15

Tissue Science Laboratories PLC19 December 2006 19 December 2006 Tissue Science Laboratories plc ('TSL' or 'the Company') Grant of Share Options to Directors Tissue Science Laboratories plc (LSE: TSL), the medical devices company specialising in tissue repair, announces today that share options have been granted to three Directors: Martin Hunt, Chief Executive 75,000 David Jennings, Finance Director 45,000 Steve Bloor, Technical Director 62,500 Date of grant: 18 December, 2006 Period during which exercisable: minimum 5 year vesting period subject to the achievement of performance conditions Description of shares involved: 182,500 of ordinary shares Exercise price: £0.715 Following the above grant of options, the above hold options over the following number of Ordinary Shares: Martin Hunt, Chief Executive 1,202,000 David Jennings, Finance Director 227,000 Steve Bloor, Technical Director 192,833 -Ends- Enquiries: TSL plc Tel: 01252 333 002Martin Hunt, Chief Executive OfficerDavid Jennings, Finance Director Hogarth Partnership Limited Tel: 020 7357 9477Sarah Richardson This information is provided by RNS The company news service from the London Stock Exchange